Japan, Feb. 6 -- NOVARTIS AG has got intellectual property rights for 'COMPOUND AND COMPOSITION FOR TREATING CONDITION RELATED TO NLRP ACTIVITY.' Other related details are as follows:
Application Number: JP,2025-044149
Category (FI): A61K31/18,A61K31/341,A61K31/343,A61K31/381,A61K31/397,A61K31/40,A61K31/415,A61K31/421,A61K31/426,A61K31/427,A61K31/435,A61K31/437,A61K31/44,A61K31/47,A61K31/5375,A61K45/00,A61P1/04,A61P1/16,A61P1/18,A61P11/00,A61P11/06,A61P13/12,A61P17/00,A61P19/02,A61P19/06,A61P19/08,A61P21/00,A61P25/00,A61P25/16,A61P25/28,A61P27/02,A61P27/06,A61P3/04,A61P3/10,A61P31/12,A61P35/00,A61P35/02,A61P35/04,A61P37/02,A61P43/00,111,A61P43/00,121,A61P9/00,A61P9/10,C07D205/04,C07D207/08,C07D207/26,C07D213/71,C07D215/36,C07D217/22,C07D2...